| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 3.19e-04 | 5 | 114 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | microtubule binding | 3.91e-04 | 308 | 114 | 8 | GO:0008017 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | CALD1 SYNE1 NUMA1 PEX14 JAKMIP3 LMOD2 CCDC88A SYNE2 CDK5RAP2 CEP295 PAWR KIF5B KIFC3 PLEC MYO18B IQGAP3 | 5.06e-04 | 1099 | 114 | 16 | GO:0008092 |
| GeneOntologyMolecularFunction | protein kinase C binding | 5.53e-04 | 66 | 114 | 4 | GO:0005080 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | CALD1 ITGA10 LAMA5 CDH23 APP ITGAX TGFBI TENM4 USO1 KIF5B PLEC | 6.37e-04 | 599 | 114 | 11 | GO:0050839 |
| GeneOntologyBiologicalProcess | intermediate filament organization | 3.33e-06 | 75 | 112 | 6 | GO:0045109 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 1.67e-05 | 99 | 112 | 6 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 1.76e-05 | 100 | 112 | 6 | GO:0045103 | |
| GeneOntologyBiologicalProcess | cellular response to norepinephrine stimulus | 8.74e-05 | 3 | 112 | 2 | GO:0071874 | |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | 1.47e-04 | 280 | 112 | 8 | GO:1902115 | |
| GeneOntologyBiologicalProcess | axon guidance | 1.66e-04 | 285 | 112 | 8 | GO:0007411 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | DMTF1 PRKD2 SP1 NACA E2F4 APP BPTF TSC22D1 USF3 CDK13 TOX3 NFYC MED12L NLRC5 NCOA1 PRKD1 KAT6B NFAT5 PRDM15 | 1.67e-04 | 1390 | 112 | 19 | GO:0045944 |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.70e-04 | 286 | 112 | 8 | GO:0097485 | |
| GeneOntologyBiologicalProcess | actomyosin contractile ring assembly actin filament organization | 1.74e-04 | 4 | 112 | 2 | GO:2000689 | |
| GeneOntologyBiologicalProcess | protein import into peroxisome matrix, docking | 1.74e-04 | 4 | 112 | 2 | GO:0016560 | |
| GeneOntologyBiologicalProcess | centriole assembly | 1.97e-04 | 53 | 112 | 4 | GO:0098534 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | CALD1 KRT34 KRT35 NUMA1 APP KRT79 LMOD2 KRT39 CCDC88A CDK5RAP2 PAWR PRKD1 PLEC IQGAP3 KRT36 | 2.08e-04 | 957 | 112 | 15 | GO:0097435 |
| GeneOntologyCellularComponent | supramolecular fiber | CALD1 KRT34 KRT35 SYNE1 NUMA1 KRT79 LMOD2 KRT39 SYNE2 SLMAP CDK5RAP2 CEP295 PAWR PRKD1 KIF5B KIFC3 PLEC MYO18B KRT36 | 1.98e-05 | 1179 | 114 | 19 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | CALD1 KRT34 KRT35 SYNE1 NUMA1 KRT79 LMOD2 KRT39 SYNE2 SLMAP CDK5RAP2 CEP295 PAWR PRKD1 KIF5B KIFC3 PLEC MYO18B KRT36 | 2.18e-05 | 1187 | 114 | 19 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | CALD1 KRT34 KRT35 NUMA1 KRT79 LMOD2 KRT39 CDK5RAP2 CEP295 PAWR KIF5B KIFC3 PLEC MYO18B KRT36 | 1.11e-04 | 899 | 114 | 15 | GO:0099513 |
| GeneOntologyCellularComponent | myofibril | 1.27e-04 | 273 | 114 | 8 | GO:0030016 | |
| GeneOntologyCellularComponent | microtubule organizing center | DTL NUMA1 CDH23 CEP76 KMT2E CCDC88A RESF1 USO1 CEP250 SLMAP NLRC5 CDK5RAP2 CEP295 KIF5B KIFC3 | 1.41e-04 | 919 | 114 | 15 | GO:0005815 |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.92e-04 | 290 | 114 | 8 | GO:0043292 | |
| GeneOntologyCellularComponent | nascent polypeptide-associated complex | 2.92e-04 | 5 | 114 | 2 | GO:0005854 | |
| GeneOntologyCellularComponent | centrosome | DTL NUMA1 CDH23 CEP76 KMT2E CCDC88A CEP250 SLMAP NLRC5 CDK5RAP2 CEP295 KIF5B KIFC3 | 2.93e-04 | 770 | 114 | 13 | GO:0005813 |
| GeneOntologyCellularComponent | sarcomere | 4.36e-04 | 249 | 114 | 7 | GO:0030017 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 6.04e-04 | 263 | 114 | 7 | GO:0045111 | |
| GeneOntologyCellularComponent | COPI-coated vesicle | 7.65e-04 | 33 | 114 | 3 | GO:0030137 | |
| GeneOntologyCellularComponent | dendrite | CALD1 SYNE1 NUMA1 LAMA2 APP PEX5L ITPR3 BPTF KCNA4 TRPM1 KIF5B PLEC CAPRIN1 | 8.10e-04 | 858 | 114 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CALD1 SYNE1 NUMA1 LAMA2 APP PEX5L ITPR3 BPTF KCNA4 TRPM1 KIF5B PLEC CAPRIN1 | 8.27e-04 | 860 | 114 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | nuclear outer membrane | 1.35e-03 | 40 | 114 | 3 | GO:0005640 | |
| GeneOntologyCellularComponent | Z disc | 1.44e-03 | 151 | 114 | 5 | GO:0030018 | |
| GeneOntologyCellularComponent | intermediate filament | 1.54e-03 | 227 | 114 | 6 | GO:0005882 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 1.57e-03 | 11 | 114 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 1.57e-03 | 11 | 114 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 1.57e-03 | 11 | 114 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 1.57e-03 | 11 | 114 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | fibrillar center | 1.66e-03 | 156 | 114 | 5 | GO:0001650 | |
| GeneOntologyCellularComponent | I band | 2.18e-03 | 166 | 114 | 5 | GO:0031674 | |
| GeneOntologyCellularComponent | COPI vesicle coat | 2.21e-03 | 13 | 114 | 2 | GO:0030126 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CALD1 SYNE1 NUMA1 LAMA2 APP PEX5L ITPR3 BPTF KCNA4 CSF1R PAWR TRPM1 KIF5B PLEC CAPRIN1 | 2.76e-03 | 1228 | 114 | 15 | GO:0036477 |
| Domain | LAMININ_IVA | 1.18e-05 | 8 | 113 | 3 | PS51115 | |
| Domain | Laminin_B | 1.18e-05 | 8 | 113 | 3 | PF00052 | |
| Domain | LamB | 1.18e-05 | 8 | 113 | 3 | SM00281 | |
| Domain | Laminin_IV | 1.18e-05 | 8 | 113 | 3 | IPR000034 | |
| Domain | Spectrin_repeat | 2.68e-05 | 29 | 113 | 4 | IPR002017 | |
| Domain | Intermediate_filament_CS | 3.94e-05 | 63 | 113 | 5 | IPR018039 | |
| Domain | Spectrin/alpha-actinin | 4.01e-05 | 32 | 113 | 4 | IPR018159 | |
| Domain | SPEC | 4.01e-05 | 32 | 113 | 4 | SM00150 | |
| Domain | IF | 7.51e-05 | 72 | 113 | 5 | PS00226 | |
| Domain | Filament | 8.03e-05 | 73 | 113 | 5 | PF00038 | |
| Domain | IF | 9.73e-05 | 76 | 113 | 5 | IPR001664 | |
| Domain | Protein_Kinase_C_mu-related | 1.08e-04 | 3 | 113 | 2 | IPR015727 | |
| Domain | Laminin_N | 1.14e-04 | 16 | 113 | 3 | IPR008211 | |
| Domain | LAMININ_NTER | 1.14e-04 | 16 | 113 | 3 | PS51117 | |
| Domain | Laminin_N | 1.14e-04 | 16 | 113 | 3 | PF00055 | |
| Domain | LamNT | 1.14e-04 | 16 | 113 | 3 | SM00136 | |
| Domain | Keratin_I | 1.43e-04 | 44 | 113 | 4 | IPR002957 | |
| Domain | KASH | 2.16e-04 | 4 | 113 | 2 | PF10541 | |
| Domain | KASH | 2.16e-04 | 4 | 113 | 2 | IPR012315 | |
| Domain | KASH | 2.16e-04 | 4 | 113 | 2 | PS51049 | |
| Domain | KASH | 2.16e-04 | 4 | 113 | 2 | SM01249 | |
| Domain | Actinin_actin-bd_CS | 3.50e-04 | 23 | 113 | 3 | IPR001589 | |
| Domain | Spectrin | 3.50e-04 | 23 | 113 | 3 | PF00435 | |
| Domain | ACTININ_2 | 3.50e-04 | 23 | 113 | 3 | PS00020 | |
| Domain | ACTININ_1 | 3.50e-04 | 23 | 113 | 3 | PS00019 | |
| Domain | Laminin_aI | 3.59e-04 | 5 | 113 | 2 | IPR009254 | |
| Domain | Laminin_I | 3.59e-04 | 5 | 113 | 2 | PF06008 | |
| Domain | Laminin_II | 3.59e-04 | 5 | 113 | 2 | PF06009 | |
| Domain | Laminin_domII | 3.59e-04 | 5 | 113 | 2 | IPR010307 | |
| Domain | CH | 6.47e-04 | 65 | 113 | 4 | SM00033 | |
| Domain | EGF_LAM_2 | 7.77e-04 | 30 | 113 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 7.77e-04 | 30 | 113 | 3 | PS01248 | |
| Domain | CH | 8.57e-04 | 70 | 113 | 4 | PF00307 | |
| Domain | Filament | 9.04e-04 | 71 | 113 | 4 | SM01391 | |
| Domain | - | 9.04e-04 | 71 | 113 | 4 | 1.10.418.10 | |
| Domain | Prefoldin | 9.52e-04 | 72 | 113 | 4 | IPR009053 | |
| Domain | CH | 1.00e-03 | 73 | 113 | 4 | PS50021 | |
| Domain | CH-domain | 1.11e-03 | 75 | 113 | 4 | IPR001715 | |
| Domain | Laminin_EGF | 1.23e-03 | 35 | 113 | 3 | PF00053 | |
| Domain | EGF_Lam | 1.23e-03 | 35 | 113 | 3 | SM00180 | |
| Domain | Laminin_EGF | 1.56e-03 | 38 | 113 | 3 | IPR002049 | |
| Domain | PHD | 2.09e-03 | 89 | 113 | 4 | SM00249 | |
| Domain | Znf_PHD | 2.27e-03 | 91 | 113 | 4 | IPR001965 | |
| Domain | ZF_PHD_2 | 2.65e-03 | 95 | 113 | 4 | PS50016 | |
| Domain | ZF_PHD_1 | 2.75e-03 | 96 | 113 | 4 | PS01359 | |
| Domain | Clathrin/coatomer_adapt-like_N | 3.62e-03 | 15 | 113 | 2 | IPR002553 | |
| Domain | Adaptin_N | 3.62e-03 | 15 | 113 | 2 | PF01602 | |
| Domain | Cadherin_CS | 4.34e-03 | 109 | 113 | 4 | IPR020894 | |
| Domain | CADHERIN_1 | 4.93e-03 | 113 | 113 | 4 | PS00232 | |
| Domain | Cadherin | 4.93e-03 | 113 | 113 | 4 | PF00028 | |
| Domain | CADHERIN_2 | 5.09e-03 | 114 | 113 | 4 | PS50268 | |
| Domain | - | 5.09e-03 | 114 | 113 | 4 | 2.60.40.60 | |
| Domain | Integrin_alpha-2 | 5.21e-03 | 18 | 113 | 2 | IPR013649 | |
| Domain | Integrin_alpha2 | 5.21e-03 | 18 | 113 | 2 | PF08441 | |
| Domain | Integrin_alpha | 5.21e-03 | 18 | 113 | 2 | IPR000413 | |
| Domain | INTEGRIN_ALPHA | 5.21e-03 | 18 | 113 | 2 | PS00242 | |
| Domain | CA | 5.25e-03 | 115 | 113 | 4 | SM00112 | |
| Domain | Cadherin-like | 5.41e-03 | 116 | 113 | 4 | IPR015919 | |
| Domain | Cadherin | 5.75e-03 | 118 | 113 | 4 | IPR002126 | |
| Domain | Int_alpha_beta-p | 5.80e-03 | 19 | 113 | 2 | IPR013519 | |
| Domain | Int_alpha | 5.80e-03 | 19 | 113 | 2 | SM00191 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DNAJC13 CALD1 TRIO RPAIN ARHGEF38 PEX14 APP MIPOL1 BPTF TSC22D1 USF3 TULP4 CDK13 GCC2 TOX3 NLRC5 PRKD1 KAT6B NFAT5 PRDM15 RAI1 | 2.86e-08 | 1489 | 118 | 21 | 28611215 |
| Pubmed | Nesprins anchor kinesin-1 motors to the nucleus to drive nuclear distribution in muscle cells. | 3.81e-08 | 3 | 118 | 3 | 25516977 | |
| Pubmed | COPB1 COPG1 NACA NUMA1 EXOSC8 MCM6 BPTF USO1 EIF3L KIF5B PLEC CAPRIN1 | 1.29e-07 | 494 | 118 | 12 | 26831064 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | HSD17B7 CALD1 COPB1 COPG1 ERCC6L SYNE1 NACA DTL NUMA1 CEP76 EIF3L CDK5RAP2 SGO2 PAWR KIFC3 CAPRIN1 IQGAP3 | 3.85e-07 | 1155 | 118 | 17 | 20360068 |
| Pubmed | 4.51e-07 | 360 | 118 | 10 | 33111431 | ||
| Pubmed | 7.56e-07 | 6 | 118 | 3 | 18827015 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | PRKD2 CALD1 COPB1 COPG1 SYNE1 NACA NUMA1 MCM6 ITPR3 CDK13 EIF3L PAWR KIF5B PLEC CAPRIN1 | 8.21e-07 | 949 | 118 | 15 | 36574265 |
| Pubmed | SP1 SYNE1 TSC22D1 USF3 CCDC88A MAP4K5 CEP250 NFYC KIF5B PLEC CPLANE1 | 8.85e-07 | 486 | 118 | 11 | 20936779 | |
| Pubmed | 1.27e-06 | 312 | 118 | 9 | 37120454 | ||
| Pubmed | COPB1 COPG1 NUMA1 MCM6 ITPR3 BPTF SYNE2 EIF3L KIF5B PLEC CAPRIN1 RAI1 | 2.42e-06 | 653 | 118 | 12 | 22586326 | |
| Pubmed | 2.48e-06 | 63 | 118 | 5 | 16831889 | ||
| Pubmed | Characterization of a 190-kilobase pair domain of human type I hair keratin genes. | 3.15e-06 | 9 | 118 | 3 | 9756910 | |
| Pubmed | 3.15e-06 | 9 | 118 | 3 | 7686952 | ||
| Pubmed | CALD1 COPG1 NUMA1 PEX14 FNDC3A ITPR3 GCC2 MTFR1 SYNE2 SLMAP KIF5B | 3.96e-06 | 568 | 118 | 11 | 37774976 | |
| Pubmed | 4.32e-06 | 124 | 118 | 6 | 35516420 | ||
| Pubmed | Nesprin 1α2 is essential for mouse postnatal viability and nuclear positioning in skeletal muscle. | 4.49e-06 | 10 | 118 | 3 | 28533284 | |
| Pubmed | The catalog of human hair keratins. I. Expression of the nine type I members in the hair follicle. | 4.49e-06 | 10 | 118 | 3 | 10391933 | |
| Pubmed | 4.49e-06 | 10 | 118 | 3 | 11784026 | ||
| Pubmed | DNAJC13 TRIO SYNE1 NUMA1 JAKMIP3 PEX5L CCDC88A KCNA4 SYNE2 CDK5RAP2 PRKD1 KIF5B CAPRIN1 RAI1 | 5.13e-06 | 963 | 118 | 14 | 28671696 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | PRKD2 HSD17B7 COPB1 COPG1 NUMA1 EXOSC8 FNDC3A MCM6 USO1 EIF3L KIF5B IQGAP3 | 5.21e-06 | 704 | 118 | 12 | 29955894 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PRKD2 TRIO KIAA0319L LAMA5 EXOSC8 LAMC3 ITPR3 TULP4 CDK13 NLRC5 KIFC3 PLEC LSM10 IQGAP3 RAI1 | 5.27e-06 | 1105 | 118 | 15 | 35748872 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 6.14e-06 | 202 | 118 | 7 | 33005030 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 6.16e-06 | 11 | 118 | 3 | 23472759 | |
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 6.16e-06 | 11 | 118 | 3 | 21524702 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | PRKD2 DNAJC13 COPG1 CCDC90B TRIM65 BPTF TSC22D1 MAP4K5 MTFR1 SYNE2 EIF3L NFYC ROBO2 KIF5B RAI1 | 6.46e-06 | 1124 | 118 | 15 | 21900206 |
| Pubmed | CALD1 KRT34 SYNE1 DTL NUMA1 KRT79 CHRNA1 MIPOL1 CCDC27 BPTF CDK13 FAM186A SYNE2 CEP295 KIF5B PLEC RAI1 | 7.66e-06 | 1442 | 118 | 17 | 35575683 | |
| Pubmed | TRIO SYNE1 LAMA2 KMT2E SYNE2 SLMAP MED12L CDK5RAP2 PLEC MYO18B | 7.98e-06 | 497 | 118 | 10 | 23414517 | |
| Pubmed | 8.19e-06 | 12 | 118 | 3 | 9396756 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | PRKD2 COPG1 KRT34 KRT35 DTL MCM6 KRT79 GCC2 EIF3L SLMAP KIF5B PLEC KRT36 NACA4P | 8.32e-06 | 1005 | 118 | 14 | 19615732 |
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 21177258 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 16226104 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 11792814 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 1.14e-05 | 2 | 118 | 2 | 24931616 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 18753385 | ||
| Pubmed | Functional redundancy of protein kinase D1 and protein kinase D2 in neuronal polarity. | 1.14e-05 | 2 | 118 | 2 | 25639845 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 22217708 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 26991731 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 24336522 | ||
| Pubmed | Interaction of Sp1 and APP promoter elucidates a mechanism for Pb2+ caused neurodegeneration. | 1.14e-05 | 2 | 118 | 2 | 31945313 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 22768332 | ||
| Pubmed | Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. | 1.14e-05 | 2 | 118 | 2 | 17267447 | |
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 1.14e-05 | 2 | 118 | 2 | 24718612 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 24586179 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 18047418 | ||
| Pubmed | The role of PKD in cell polarity, biosynthetic pathways, and organelle/F-actin distribution. | 1.14e-05 | 2 | 118 | 2 | 24492625 | |
| Pubmed | Unique functions for protein kinase D1 and protein kinase D2 in mammalian cells. | 1.14e-05 | 2 | 118 | 2 | 20819079 | |
| Pubmed | Genomic analysis of recurrences and high-grade forms of polymorphous adenocarcinoma. | 1.14e-05 | 2 | 118 | 2 | 30843621 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 17761684 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 31578382 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 36872774 | ||
| Pubmed | SP1 ERCC6L LRRC37A3 LMOD2 ITPR3 GCC2 SYNE2 NCOA1 CDK5RAP2 CEP295 RAI1 | 1.18e-05 | 638 | 118 | 11 | 31182584 | |
| Pubmed | 1.34e-05 | 151 | 118 | 6 | 17043677 | ||
| Pubmed | NACA LAMA5 FNDC3A CCDC88A SLMAP MED12L CDK5RAP2 ROBO2 KAT6B RAI1 | 1.37e-05 | 529 | 118 | 10 | 14621295 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 1.68e-05 | 15 | 118 | 3 | 15895400 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.69e-05 | 430 | 118 | 9 | 35044719 | |
| Pubmed | 2.06e-05 | 16 | 118 | 3 | 17601529 | ||
| Pubmed | 2.52e-05 | 101 | 118 | 5 | 10997877 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PRKD2 COPB1 TRIO COPG1 SYNE1 NACA NUMA1 MCM6 LAMC3 USO1 EIF3L SGO2 KIF5B MYO18B CAPRIN1 IQGAP3 | 2.63e-05 | 1425 | 118 | 16 | 30948266 |
| Pubmed | 2.99e-05 | 18 | 118 | 3 | 11311202 | ||
| Pubmed | Functional and therapeutic significance of protein kinase D enzymes in invasive breast cancer. | 3.42e-05 | 3 | 118 | 2 | 26253275 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 10225960 | ||
| Pubmed | Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: revisited. | 3.42e-05 | 3 | 118 | 2 | 15745965 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 12134073 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 26045048 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 27662904 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 21488147 | ||
| Pubmed | The inner nuclear membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelope. | 3.42e-05 | 3 | 118 | 2 | 16079285 | |
| Pubmed | Accessible chromatin structure permits factors Sp1 and Sp3 to regulate human TGFBI gene expression. | 3.42e-05 | 3 | 118 | 2 | 21554857 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 11597768 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 10364433 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 22412893 | ||
| Pubmed | Effect of deletion of the protein kinase PRKD1 on development of the mouse embryonic heart. | 3.42e-05 | 3 | 118 | 2 | 38419169 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 31882770 | ||
| Pubmed | Expression of the protein kinase D (PKD) family during mouse embryogenesis. | 3.42e-05 | 3 | 118 | 2 | 16377259 | |
| Pubmed | The AR/NCOA1 axis regulates prostate cancer migration by involvement of PRKD1. | 3.42e-05 | 3 | 118 | 2 | 27255895 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 10878022 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 32747433 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 8568931 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 26426580 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 12408964 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 20497126 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 17462627 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 10720466 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 20498078 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 19581308 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 33472039 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 27479907 | ||
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 3.49e-05 | 179 | 118 | 6 | 36261009 | |
| Pubmed | 3.55e-05 | 19 | 118 | 3 | 27234308 | ||
| Pubmed | 4.16e-05 | 20 | 118 | 3 | 22911573 | ||
| Pubmed | TRIO ERCC6L NACA DTL AKAP3 FNDC3A CCDC88A USO1 EIF3L CEP295 R3HDM1 | 4.20e-05 | 733 | 118 | 11 | 34672954 | |
| Pubmed | 4.46e-05 | 187 | 118 | 6 | 26460568 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CALD1 COPB1 SYNE1 NACA NUMA1 MCM6 APP ITPR3 BPTF SYNE2 PAWR KIF5B PLEC | 4.65e-05 | 1024 | 118 | 13 | 24711643 |
| Pubmed | Schwann cell myelination requires integration of laminin activities. | 4.84e-05 | 21 | 118 | 3 | 22767514 | |
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 18368381 | ||
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 16648470 | ||
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 28428613 | ||
| Pubmed | SLIT2/ROBO1 signaling suppresses mTORC1 for organelle control and bacterial killing. | 6.82e-05 | 4 | 118 | 2 | 37311584 | |
| Pubmed | Comparison of the PTS1- and Rab8b-binding properties of Pex5p and Pex5Rp/TRIP8b. | 6.82e-05 | 4 | 118 | 2 | 18346465 | |
| Pubmed | 6.82e-05 | 4 | 118 | 2 | 22555292 | ||
| Interaction | KRT78 interactions | 6.57e-07 | 87 | 115 | 7 | int:KRT78 | |
| Interaction | TFDP3 interactions | 1.81e-06 | 36 | 115 | 5 | int:TFDP3 | |
| Interaction | SMARCE1 interactions | KRT34 KRT35 NUMA1 E2F4 CEP76 MIPOL1 KRT39 NCOA1 KIFC3 CCDC183 | 5.87e-06 | 287 | 115 | 10 | int:SMARCE1 |
| Interaction | MYOZ1 interactions | 7.02e-06 | 47 | 115 | 5 | int:MYOZ1 | |
| Interaction | PIN1 interactions | SP1 KRT34 CCDC90B E2F4 CEP76 APP MTFR1 TOX3 KIFC3 CAPRIN1 RAI1 | 1.23e-05 | 383 | 115 | 11 | int:PIN1 |
| Interaction | ARHGAP42 interactions | 2.36e-05 | 60 | 115 | 5 | int:ARHGAP42 | |
| Interaction | NUP62 interactions | 2.71e-05 | 273 | 115 | 9 | int:NUP62 | |
| Interaction | KRT4 interactions | 2.77e-05 | 62 | 115 | 5 | int:KRT4 | |
| Interaction | PLEC interactions | SP1 KRT34 NACA LAMA5 CCDC27 KRT39 CCDC88A SYNE2 PRKD1 PLEC MYO18B | 3.57e-05 | 430 | 115 | 11 | int:PLEC |
| Interaction | CCDC196 interactions | 3.62e-05 | 33 | 115 | 4 | int:CCDC196 | |
| Interaction | KRT83 interactions | 4.34e-05 | 68 | 115 | 5 | int:KRT83 | |
| Interaction | MLF1 interactions | 4.66e-05 | 113 | 115 | 6 | int:MLF1 | |
| Interaction | H2BC9 interactions | ERCC6L NUMA1 LAMA2 MCM6 BPTF FHAD1 USF3 DENND2C TRPM1 KAT6B RAI1 | 4.97e-05 | 446 | 115 | 11 | int:H2BC9 |
| Interaction | KRT74 interactions | 5.75e-05 | 37 | 115 | 4 | int:KRT74 | |
| Interaction | LENG1 interactions | 6.22e-05 | 119 | 115 | 6 | int:LENG1 | |
| Interaction | TXLNA interactions | 6.33e-05 | 236 | 115 | 8 | int:TXLNA | |
| Interaction | KRT86 interactions | 6.96e-05 | 75 | 115 | 5 | int:KRT86 | |
| Interaction | KRT6C interactions | 7.42e-05 | 76 | 115 | 5 | int:KRT6C | |
| Interaction | KRT75 interactions | 8.13e-05 | 181 | 115 | 7 | int:KRT75 | |
| Interaction | FGL2 interactions | 9.60e-05 | 16 | 115 | 3 | int:FGL2 | |
| Interaction | SCAND2P interactions | 9.65e-05 | 3 | 115 | 2 | int:SCAND2P | |
| Interaction | PCDHB4 interactions | 9.65e-05 | 3 | 115 | 2 | int:PCDHB4 | |
| Interaction | CCDC14 interactions | 9.74e-05 | 129 | 115 | 6 | int:CCDC14 | |
| Interaction | SCNM1 interactions | 1.38e-04 | 197 | 115 | 7 | int:SCNM1 | |
| Interaction | HERC2 interactions | COPG1 FNDC3A CCDC88A GCC2 CEP250 SYNE2 EIF3L KIF5B KIFC3 PLEC RAI1 | 1.44e-04 | 503 | 115 | 11 | int:HERC2 |
| Interaction | KRT3 interactions | 1.49e-04 | 88 | 115 | 5 | int:KRT3 | |
| Interaction | LRRC31 interactions | 1.76e-04 | 205 | 115 | 7 | int:LRRC31 | |
| GeneFamily | Keratins, type I | 3.71e-06 | 28 | 69 | 4 | 608 | |
| GeneFamily | Laminin subunits | 1.14e-05 | 12 | 69 | 3 | 626 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 8.57e-05 | 4 | 69 | 2 | 1252 | |
| GeneFamily | Cadherin related | 1.88e-03 | 17 | 69 | 2 | 24 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.88e-03 | 17 | 69 | 2 | 486 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 2.11e-03 | 18 | 69 | 2 | 1160 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 4.07e-03 | 25 | 69 | 2 | 504 | |
| GeneFamily | PHD finger proteins | 4.93e-03 | 90 | 69 | 3 | 88 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | DNAJC13 TRIO PEX14 FNDC3A APP BPTF CDK13 MAP4K5 GCC2 MTFR1 SYNE2 NFYC NCOA1 PAWR R3HDM1 KAT6B | 1.51e-06 | 856 | 118 | 16 | M4500 |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | 4.23e-06 | 432 | 118 | 11 | MM419 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | DNAJC13 TRIO FNDC3A BPTF CDK13 MAP4K5 NFYC NCOA1 PAWR R3HDM1 KAT6B | 8.65e-06 | 466 | 118 | 11 | M13522 |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | CALD1 KRT34 KRT35 NUMA1 LAMA2 LAMA5 APP KRT79 ITPR3 TENM4 PLEC KRT36 | 2.05e-05 | 610 | 118 | 12 | M3854 |
| Coexpression | GSE6259_CD4_TCELL_VS_CD8_TCELL_UP | 2.27e-05 | 187 | 118 | 7 | M6738 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_UP | 3.28e-05 | 198 | 118 | 7 | M9929 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_LUNG_DN | 3.39e-05 | 199 | 118 | 7 | M4350 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | CALD1 KRT34 KRT35 NUMA1 LAMA2 LAMA5 APP KRT79 ITPR3 TENM4 PLEC KRT36 | 3.81e-05 | 650 | 118 | 12 | MM1042 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | DNAJC13 CALD1 BPTF CCDC88A RESF1 GCC2 SYNE2 SLMAP CDK5RAP2 TRPM1 KIF5B CPLANE1 | 4.16e-05 | 656 | 118 | 12 | M18979 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | SP1 DNAJC13 CALD1 TRIO FNDC3A KMT2E TGFBI TENM4 RESF1 CSF1R TULP4 SYNE2 ROBO2 CEP295 PLEC R3HDM1 CPLANE1 NFAT5 | 3.46e-07 | 801 | 116 | 18 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | SP1 DNAJC13 CALD1 TRIO KMT2E TENM4 RESF1 CSF1R TULP4 SYNE2 ROBO2 CEP295 PLEC R3HDM1 CPLANE1 NFAT5 | 6.25e-06 | 790 | 116 | 16 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | SP1 DNAJC13 CALD1 KMT2E TENM4 RESF1 SYNE2 ROBO2 CEP295 R3HDM1 CPLANE1 | 1.67e-05 | 413 | 116 | 11 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.95e-05 | 151 | 116 | 7 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.05e-05 | 275 | 116 | 9 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 2.69e-05 | 107 | 116 | 6 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | SP1 DNAJC13 CALD1 FNDC3A KMT2E TENM4 RESF1 MTFR1 SYNE2 ROBO2 CEP295 PRKD1 R3HDM1 CPLANE1 NFAT5 | 3.25e-05 | 804 | 116 | 15 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+F4/80lo.Kd, CD45+ CD11c+ I-A/I-E+ CD11b+ F4/80lo, Kidney, avg-3 | 4.98e-05 | 73 | 116 | 5 | GSM854273_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.05e-05 | 127 | 116 | 6 | gudmap_developingGonad_e16.5_epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | SP1 DNAJC13 CALD1 KMT2E RESF1 SYNE2 ROBO2 CEP295 R3HDM1 CPLANE1 | 7.87e-05 | 406 | 116 | 10 | gudmap_developingGonad_e16.5_epididymis_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | SP1 DNAJC13 KMT2E KRT79 TENM4 RESF1 TULP4 MTFR1 SYNE2 CEP295 PLEC R3HDM1 CPLANE1 NFAT5 | 8.90e-05 | 778 | 116 | 14 | gudmap_developingGonad_e18.5_ovary_1000 |
| ToppCell | IPF-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | ENOX1 ANKRD20A2P ANKRD20A3P TENM4 MED12L NLRC5 PAWR ANKRD20A1 | 3.70e-08 | 188 | 117 | 8 | 47bb6caf84f70a1cda7d09803afdfd5182772e66 |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ENOX1 CDH23 ANKRD20A2P ANKRD20A3P ITGAX CCDC88A MED12L NLRC5 | 5.52e-08 | 198 | 117 | 8 | fa5c15a656d4132950092919600e270f1fd79abf |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.98e-07 | 174 | 117 | 7 | 65147b0f8c2ccadd5685430d31081520c157536a | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 6.23e-07 | 186 | 117 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Control-Endothelial-VE_Capillary_A|Control / Disease state, Lineage and Cell class | 6.46e-07 | 187 | 117 | 7 | 54d7588172ac145ff5045ad9771636729ca3f0ca | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.98e-07 | 193 | 117 | 7 | a332dfdcc48c405020014e644aa4d14fda98cc86 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.55e-07 | 195 | 117 | 7 | c1435e61e4f0cf457f26ae436936048932ceb0db | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.80e-07 | 199 | 117 | 7 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 9.80e-07 | 199 | 117 | 7 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.01e-06 | 200 | 117 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.01e-06 | 200 | 117 | 7 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 1.55e-06 | 135 | 117 | 6 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 3.59e-06 | 156 | 117 | 6 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.87e-06 | 158 | 117 | 6 | 410fa08c9d880d27e80ec939fa5ba5a41dcb31ab | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.47e-06 | 162 | 117 | 6 | 3f264263878af630921911c2b344ac56eb1e7099 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 5.14e-06 | 166 | 117 | 6 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|normal_Lymph_Node / Location, Cell class and cell subclass | 7.18e-06 | 176 | 117 | 6 | 476794ef75ce5ab732d78cfeb4944e2f841e3e92 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.42e-06 | 177 | 117 | 6 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.91e-06 | 179 | 117 | 6 | ff678e2f33c914e3dd0f338ada25f506c3e3c980 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.43e-06 | 181 | 117 | 6 | 9c157de9d3403e092c907599f2a2c16db5b21131 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.43e-06 | 181 | 117 | 6 | eea943fdcbef0bbaa8578f3296923e874893b405 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.70e-06 | 182 | 117 | 6 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 8.97e-06 | 183 | 117 | 6 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.97e-06 | 183 | 117 | 6 | bc7dd6a40ec9c773d005c1a46f305d40cdd0a326 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.26e-06 | 184 | 117 | 6 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 9.26e-06 | 184 | 117 | 6 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-ACTC+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.26e-06 | 184 | 117 | 6 | 39168ca2bbf1369c9fe87c67f0aaff5e3cd03151 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.26e-06 | 184 | 117 | 6 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.55e-06 | 185 | 117 | 6 | 57c1eb50a4456d20953e48d5dc3b0ea3d0d81b6d | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.55e-06 | 185 | 117 | 6 | b4af9ae4c358b48357cb135b740266e1652d886a | |
| ToppCell | Control-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 9.55e-06 | 185 | 117 | 6 | a28187c2fd23564314b35759479ff2ca21f61485 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.84e-06 | 186 | 117 | 6 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-05 | 188 | 117 | 6 | 95d0a796d62ce6d121e2028c378faffc14b35275 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 1.08e-05 | 189 | 117 | 6 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 190 | 117 | 6 | 86ab845a7fae2111c0b01e1aec235e19c4c0ef5c | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.11e-05 | 190 | 117 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-05 | 190 | 117 | 6 | 251e3a33041023bfc4b547c7eb68cfb8f421636f | |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 1.14e-05 | 191 | 117 | 6 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.18e-05 | 192 | 117 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Stem_cells|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.21e-05 | 193 | 117 | 6 | 3091090abcf18b48eac7e6c85653c18aa54fcb9b | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.21e-05 | 193 | 117 | 6 | a594f89a18273797506287d9e22f72abe53e4920 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Stem_cells-Stem_cells|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.21e-05 | 193 | 117 | 6 | a18770ceb770aaa4903dd04442ad0a73159ead9a | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-05 | 193 | 117 | 6 | f25bdd10ef531b8d8441ea84573078b4b1b0f105 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-05 | 194 | 117 | 6 | effd38e51062b225ecabc7e1c50154e65495d559 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-IPC_like-IPCs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.25e-05 | 194 | 117 | 6 | 2378a98452f6ec33870eeb994b8b812e9b507f4c | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-IPC_like|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.25e-05 | 194 | 117 | 6 | 7ba0445a486feac18b3a4fd6f2855c102e374e2d | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-05 | 195 | 117 | 6 | b0d408f8bc1701a87596ed55efcd90749fee33e6 | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.29e-05 | 195 | 117 | 6 | 1daddd801bd4596fffbdb822fc326d5127c96004 | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.29e-05 | 195 | 117 | 6 | 01a750d660993017af00736215cbcff2de5909c1 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-05 | 195 | 117 | 6 | a486a7acea0e91048cc48afa0dbd3926d30bc217 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-05 | 195 | 117 | 6 | 2414b158dc7bdec43a9671544bfb7ffc5f5168fd | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 1.33e-05 | 196 | 117 | 6 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.33e-05 | 196 | 117 | 6 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 1.33e-05 | 196 | 117 | 6 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.33e-05 | 196 | 117 | 6 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-05 | 197 | 117 | 6 | 9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-05 | 198 | 117 | 6 | b2d295e330772bd8e24da356c75564b4297ea9c5 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-05 | 198 | 117 | 6 | ce59ee3d970397eb62d6387699c6c6cd65457898 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.40e-05 | 198 | 117 | 6 | 880f9817f5145f10f29fc05c5866090433532fe2 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.40e-05 | 198 | 117 | 6 | 08d393853e195a7eacace454153e425a273e2d23 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-05 | 198 | 117 | 6 | 3ffaea4b44067d69f954b2bd3119c88a55ab232a | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.44e-05 | 199 | 117 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM3|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.44e-05 | 199 | 117 | 6 | 30523cf08815ca214877e33a2c52197ff8318557 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.44e-05 | 199 | 117 | 6 | 105709b97c55826a852aed27658e3b4af1738c8a | |
| ToppCell | Basal|World / shred by cell class for turbinate | 1.44e-05 | 199 | 117 | 6 | d9fe184a7d3251f871eba3123e0127aa1a6f2949 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.44e-05 | 199 | 117 | 6 | 0892957a49304ce4b6daa3657d76d8365ce0dd19 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.44e-05 | 199 | 117 | 6 | b2dc3d0af6ecd3ab01779aaa1f061cb0f941cae8 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 1.44e-05 | 199 | 117 | 6 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.44e-05 | 199 | 117 | 6 | 961ad44199871be8e09d31904d383edc865ba262 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 1.44e-05 | 199 | 117 | 6 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.49e-05 | 200 | 117 | 6 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.49e-05 | 200 | 117 | 6 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.49e-05 | 200 | 117 | 6 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.49e-05 | 200 | 117 | 6 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.49e-05 | 200 | 117 | 6 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.49e-05 | 200 | 117 | 6 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.49e-05 | 200 | 117 | 6 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.49e-05 | 200 | 117 | 6 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | (54)_pDC|World / shred on Cell_type and subtype | 1.62e-05 | 203 | 117 | 6 | b8ba3e51770ff7b45cd02472f3e63aa4d5816f6f | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-immature_Neutrophil-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.68e-05 | 142 | 117 | 5 | e160f35b3c18e77c4107fe96db5f56227c91785e | |
| ToppCell | COVID-19_Moderate-multiplets|COVID-19_Moderate / disease group, cell group and cell class | 4.34e-05 | 147 | 117 | 5 | baf15c773d7751bc6f64d4974a22738626f2b3ff | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-05 | 152 | 117 | 5 | d279592c501fca9cb474ad916fea32282e6969cb | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-05 | 152 | 117 | 5 | 3b59143b2b4ee24eb6378f87ff568124193256e9 | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.59e-05 | 155 | 117 | 5 | ced64e26962c5c6e6d539f361fe57ab0b399e999 | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.59e-05 | 155 | 117 | 5 | 0f24ef6486aef354f0911c06932cb01d1a0525ac | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-Migrating_MyoFibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.59e-05 | 155 | 117 | 5 | 1882fa5fd25f77d6e3ac47b613f6fb3c67d8e50c | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.59e-05 | 155 | 117 | 5 | d8b5145258f075b15080f8739f537f48dd22225e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.76e-05 | 156 | 117 | 5 | 6365b69ede98bc866e996bc52736b00401aacf6f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.94e-05 | 157 | 117 | 5 | bfec34182f052cf1c0d847ba53ea335d4d1190de | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.94e-05 | 157 | 117 | 5 | 7fdc0094dd5729990a91a30c1982a14c74650b52 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.94e-05 | 157 | 117 | 5 | c762b03e254c73222094725ca8ac1c8eb428bccb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.94e-05 | 157 | 117 | 5 | 6b5b08bb5520fcf6f4c0560f7ed7645ec179806d | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-05 | 162 | 117 | 5 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-05 | 164 | 117 | 5 | 1a9b444d2c6abcc83d4355ec5228b27541df2bd0 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.51e-05 | 165 | 117 | 5 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.41e-05 | 169 | 117 | 5 | 1d5ce2c97f7ef7bdc9f861938077a9aa31d84db6 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.41e-05 | 169 | 117 | 5 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.41e-05 | 169 | 117 | 5 | 58098f8801ca941aeddafb47e88ab0df8b9edb57 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.41e-05 | 169 | 117 | 5 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.65e-05 | 170 | 117 | 5 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.03e-05 | 49 | 74 | 5 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | AC1L1B58 | 3.54e-07 | 29 | 117 | 5 | CID000001288 | |
| Drug | kalinin | 3.82e-07 | 55 | 117 | 6 | CID000032518 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 2.92e-06 | 171 | 117 | 8 | 7535_DN | |
| Drug | 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | 5.23e-06 | 314 | 117 | 10 | CID000003542 | |
| Drug | Amiprilose hydrochloride [60414-06-4]; Down 200; 11.8uM; HL60; HT_HG-U133A | 8.62e-06 | 198 | 117 | 8 | 3000_DN | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 8.07e-05 | 4 | 109 | 2 | cv:CN293514 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.07e-04 | 291 | 109 | 7 | EFO_0008317, EFO_0020946 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 1.20e-04 | 206 | 109 | 6 | EFO_0004612, EFO_0020947 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 1.34e-04 | 5 | 109 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 1.34e-04 | 5 | 109 | 2 | C0410190 | |
| Disease | Emery-Dreifuss muscular dystrophy | 2.01e-04 | 6 | 109 | 2 | cv:C0410189 | |
| Disease | low density lipoprotein cholesterol measurement, body mass index | 2.01e-04 | 6 | 109 | 2 | EFO_0004340, EFO_0004611 | |
| Disease | Congenital muscular dystrophy (disorder) | 2.01e-04 | 6 | 109 | 2 | C0699743 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 2.01e-04 | 6 | 109 | 2 | C0410189 | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 2.04e-04 | 31 | 109 | 3 | EFO_0022249 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 2.81e-04 | 7 | 109 | 2 | C0751337 | |
| Disease | unipolar depression, bipolar disorder | 2.91e-04 | 156 | 109 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | non-high density lipoprotein cholesterol measurement | 3.17e-04 | 713 | 109 | 10 | EFO_0005689 | |
| Disease | grip strength measurement | 3.29e-04 | 350 | 109 | 7 | EFO_0006941 | |
| Disease | phenol sulfate measurement | 3.73e-04 | 8 | 109 | 2 | EFO_0021011 | |
| Disease | lactase-phlorizin hydrolase measurement | 3.73e-04 | 8 | 109 | 2 | EFO_0801753 | |
| Disease | Psychotic Disorders | 5.46e-04 | 101 | 109 | 4 | C0033975 | |
| Disease | octadecanedioate measurement | 5.97e-04 | 10 | 109 | 2 | EFO_0021056 | |
| Disease | Leukoencephalopathy | 7.28e-04 | 11 | 109 | 2 | C0270612 | |
| Disease | level of Ceramide (d40:1) in blood serum | 7.28e-04 | 11 | 109 | 2 | OBA_2045185 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 7.98e-04 | 49 | 109 | 3 | EFO_0022256 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 8.71e-04 | 12 | 109 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | ADHD symptom measurement | 8.71e-04 | 12 | 109 | 2 | EFO_0007860 | |
| Disease | triglycerides in LDL measurement | 1.18e-03 | 56 | 109 | 3 | EFO_0022320 | |
| Disease | total lipids in medium HDL measurement | 1.31e-03 | 58 | 109 | 3 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 1.31e-03 | 58 | 109 | 3 | EFO_0022267 | |
| Disease | forced expiratory volume, response to bronchodilator | 1.35e-03 | 445 | 109 | 7 | EFO_0004314, GO_0097366 | |
| Disease | cholesterol in medium HDL measurement | 1.37e-03 | 59 | 109 | 3 | EFO_0021903 | |
| Disease | bipolar disorder | 1.38e-03 | 577 | 109 | 8 | MONDO_0004985 | |
| Disease | Peroxisome biogenesis disorders | 1.38e-03 | 15 | 109 | 2 | C1832200 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.43e-03 | 222 | 109 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | response to antipsychotic drug | 1.44e-03 | 60 | 109 | 3 | GO_0097332 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 1.44e-03 | 60 | 109 | 3 | EFO_0022237 | |
| Disease | phospholipids in HDL measurement | 1.51e-03 | 61 | 109 | 3 | EFO_0022293 | |
| Disease | total lipids in HDL measurement | 1.66e-03 | 63 | 109 | 3 | EFO_0022307 | |
| Disease | Dementia | 1.77e-03 | 17 | 109 | 2 | C0497327 | |
| Disease | muscular dystrophy (is_implicated_in) | 1.77e-03 | 17 | 109 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | total lipids in very large HDL measurement | 1.89e-03 | 66 | 109 | 3 | EFO_0022312 | |
| Disease | phospholipids in very large HDL measurement | 1.89e-03 | 66 | 109 | 3 | EFO_0022298 | |
| Disease | infant grey matter volume measurement | 1.99e-03 | 18 | 109 | 2 | EFO_0008368 | |
| Disease | Malignant neoplasm of breast | SYNE1 ARHGEF38 LAMA2 JAKMIP3 CSF1R SYNE2 TOX3 NFYC NLRC5 NCOA1 KAT6B | 2.10e-03 | 1074 | 109 | 11 | C0006142 |
| Disease | cholesterol in very large HDL measurement | 2.15e-03 | 69 | 109 | 3 | EFO_0022229 | |
| Disease | breast size | 2.15e-03 | 69 | 109 | 3 | EFO_0004884 | |
| Disease | Nonorganic psychosis | 2.15e-03 | 69 | 109 | 3 | C0349204 | |
| Disease | Cholecystitis | 2.22e-03 | 19 | 109 | 2 | HP_0001082 | |
| Disease | acetate measurement | 2.46e-03 | 20 | 109 | 2 | EFO_0010112 | |
| Disease | myeloid white cell count | DNAJC13 RPAIN ITGA10 CDH23 MCM6 KMT2E MAP4K5 MED12L NLRC5 PAWR | 2.49e-03 | 937 | 109 | 10 | EFO_0007988 |
| Disease | Paroxysmal atrial fibrillation | 2.72e-03 | 156 | 109 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 2.72e-03 | 156 | 109 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 2.72e-03 | 156 | 109 | 4 | C2585653 | |
| Disease | Atrial Fibrillation | 2.98e-03 | 160 | 109 | 4 | C0004238 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 3.03e-03 | 264 | 109 | 5 | EFO_0008317, EFO_0020944 | |
| Disease | free cholesterol in large HDL measurement | 3.16e-03 | 79 | 109 | 3 | EFO_0022157 | |
| Disease | apolipoprotein B measurement | 3.24e-03 | 663 | 109 | 8 | EFO_0004615 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 3.40e-03 | 166 | 109 | 4 | EFO_0004530, EFO_0004611 | |
| Disease | HDL cholesterol change measurement | 3.54e-03 | 24 | 109 | 2 | EFO_0007805 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALETVQNDLSQTQQQ | 691 | Q5TYW2 | |
| ISTITNNIQQIIEIE | 236 | Q15582 | |
| VQNAILQAVQQVSQE | 26 | P0CW23 | |
| QTVLNEAQVTIIVEN | 411 | Q96JP9 | |
| QITNVVEANQPVTIQ | 81 | P05067 | |
| SSISEIQNQVLEEIQ | 521 | Q9NXL2 | |
| QISTNEIQSDQNLKV | 236 | Q9UKU9 | |
| LNQTLSQEVVNTQLA | 256 | Q8TAP6 | |
| QQSVTVVLFQDENTL | 216 | Q9NZJ0 | |
| QIQNVVTVQAASVQE | 2611 | Q12830 | |
| EMVTQAQQEITVQQL | 101 | Q9GZT6 | |
| VEQTELQQEQLQTVV | 556 | Q14444 | |
| STTTVLVNVNDINDN | 1726 | Q9H251 | |
| TEGTVTQIQILQNEQ | 101 | Q9Y222 | |
| VQVLNIKVNSETQQQ | 1111 | Q14004 | |
| ATQEVVTQLQSQILE | 956 | Q96SN8 | |
| TKVSQLQEQVELDQN | 531 | Q2M243 | |
| ISQENQEKIQIQLTQ | 96 | Q15032 | |
| TALTSQVENISNTVQ | 436 | Q7Z5J4 | |
| QVENISNTVQQLLLS | 441 | Q7Z5J4 | |
| DAITQQNTIQNEAVN | 191 | Q96IZ0 | |
| SQFIADVIENSQIIQ | 106 | Q96B26 | |
| NVVNQNVLTTSVNDE | 66 | Q86VS3 | |
| EQVVSEQTLVQSNIC | 641 | P20702 | |
| ENSTSLQTHQTIVVQ | 1486 | Q14573 | |
| TVQAVQSLTQESSEQ | 1541 | Q8WYB5 | |
| VQTANEVKQAVEQQI | 691 | P33176 | |
| INVDEVNQIVTTNVR | 61 | P02708 | |
| ALETVQNDLSQTQQQ | 691 | Q5SQ80 | |
| VDLEQFNQQLSTTIQ | 66 | Q14566 | |
| DQFEIQLTQQLQSVI | 1471 | O60309 | |
| VSNCQIQENVDISTV | 566 | Q15139 | |
| DDVNITSTIEQQLQI | 86 | Q969L4 | |
| VTSQISNNVLEQITS | 801 | Q86YW9 | |
| IVSITQQQNEELATQ | 376 | Q8TD10 | |
| IEELNQQVVTSSQQQ | 291 | Q6A163 | |
| VFSDEVQQQAQLSTI | 446 | Q9Y262 | |
| QQATAQVTVIVQPEN | 581 | Q8IZA0 | |
| ELSQVQTHVSNTNVV | 286 | Q5XKE5 | |
| VNLNNIENITTQTLT | 216 | Q6P5Q4 | |
| VSLQEQNTTLQTQNA | 1091 | Q3V6T2 | |
| ISENQEAQNQVTISA | 296 | Q8IYB4 | |
| LDVLVVNQTSDTLQN | 741 | P53618 | |
| VTSQQNDIENTVLTI | 686 | Q8IZD2 | |
| NANLTNEEQVVVIQA | 666 | Q5VZ66 | |
| SISVSNSQIQENVDI | 531 | Q9BZL6 | |
| QNFLQSQVVVEESIL | 476 | Q96PP9 | |
| QKQANISIVDIDTNQ | 2431 | P24043 | |
| QSEELNQQVVSSSEQ | 291 | Q92764 | |
| QQLEVLEQQSTSLGQ | 2231 | O15230 | |
| DLVQQVLEAQQQLSS | 796 | O94916 | |
| DLQATVSQVNAQTQE | 506 | Q86VI3 | |
| KETLQITQTEVQQGQ | 291 | Q13952 | |
| AENTQQLINVVVISV | 521 | Q9P2V4 | |
| TEISISETQQQLCVQ | 1411 | Q86WI3 | |
| KTQQNITVQVSDVND | 431 | Q9Y5E5 | |
| IVTQQEQQNLTAGDL | 161 | Q15390 | |
| ALETVQNDLSQTQQQ | 691 | Q5VUR7 | |
| LNLSSEQNLIQEVTV | 301 | P07333 | |
| EQNVVLVQQQSKELS | 1041 | B1AJZ9 | |
| QNQQSEFTIENLVIT | 276 | P33261 | |
| VQQSIRNVTEDVQNS | 121 | Q16254 | |
| NLPDTQQLVQQSQSV | 2076 | Q9H799 | |
| VSADGTQQVILVQVN | 26 | Q9Y2H6 | |
| SSLFEAQQQNSVIEV | 771 | Q9BV73 | |
| NLQINVSELQTLQSE | 1371 | Q8IWJ2 | |
| EQTQELKTITQLQEQ | 11 | Q5T5S1 | |
| TQIVQLTQQVDTNIS | 246 | Q8IWF6 | |
| EVTIVQVDVSNLQSV | 56 | P56937 | |
| ILTQEQNFSQDVTLN | 801 | Q68D51 | |
| QLALEVVNIVTSNQD | 1791 | O75165 | |
| VVNIVTSNQDCVNNI | 1796 | O75165 | |
| QVITNNASCIVQNLT | 1006 | O75578 | |
| LVQQQNVQLSLTEAT | 171 | P38567 | |
| TNTLNDQTLENVTVQ | 666 | Q9Y678 | |
| QAQTQEITLTPQQAQ | 1331 | A6NE01 | |
| ITLQQSQQSQPVELD | 386 | Q5H9B9 | |
| SLAQQENLTILQEQS | 1156 | Q9C0D2 | |
| SNEINVLTVALVNQD | 536 | Q8TC92 | |
| EDLQNSVTQLQLQSL | 631 | Q2NKX8 | |
| ITNESQNAESNVSII | 901 | Q2NKX8 | |
| TQTEELNQQVVSSSE | 286 | O76013 | |
| TESNQVVQFETINLN | 696 | Q9Y4K4 | |
| ELTTLNATIQQQDQE | 506 | Q14980 | |
| TQQSITVQVSDVNDN | 431 | Q9Y5E3 | |
| EQLQTAVTQQVSQIQ | 681 | O60763 | |
| EIQQELINQEQSIIS | 96 | Q86UA6 | |
| IQQTEQTIEQKLVQA | 4111 | Q8NF91 | |
| IQVSVTNLEELNVVQ | 4336 | Q8NF91 | |
| TVDFVNQSVLQISSQ | 6966 | Q8NF91 | |
| TQSIQELSNQVTALQ | 3861 | Q8WXH0 | |
| TEQQLAAQLVTLQNE | 171 | A6NGB0 | |
| SQLSQVQSLITNVES | 351 | O76011 | |
| NDQQISQESRNSTVV | 871 | Q9HCM1 | |
| SQQDVFQEVQALVTS | 501 | Q9BVG8 | |
| QVQQVQVFADVQCTV | 1386 | Q15788 | |
| DETNSAVQSIQQVVV | 1336 | P57071 | |
| TISENLQVTNEFQTV | 851 | Q562F6 | |
| QSQISQVQLQSQELS | 541 | Q15714 | |
| QQQNVEATVLVDSVL | 66 | Q8NE31 | |
| TTQAISQETLQNLQL | 426 | P08047 | |
| QTVTQLQTTLASVQE | 161 | O75381 | |
| TVIVSNHNLTDTVQN | 756 | O75969 | |
| QVTDQVEVNAQNSVP | 61 | Q05682 | |
| NQNVQLDVLTNQTTA | 716 | Q9NRJ4 | |
| VVLQAVLTFEQQDIQ | 176 | Q5VTQ0 | |
| EELQQINETSQSQLN | 226 | Q96KP6 | |
| NQVEESTKQIQVLQA | 536 | Q14BN4 | |
| LDIIQETQVPVSQQN | 876 | Q6N022 | |
| LENGVNVTVSQINTV | 2641 | Q6N022 | |
| DQQIQTPSVQDLQIV | 6 | Q9GZW5 | |
| ITENNNSITEQITDV | 841 | Q9HCK4 | |
| VSNQTVGQQIVIIQA | 571 | Q68DE3 | |
| IQSQTQTQVLSQVSI | 561 | O15405 | |
| ELQQTLQQEQSVLDQ | 2201 | Q15149 | |
| SALEQQKIQSQQENT | 1696 | Q8IUG5 | |
| QNTQLTVETTNIEGT | 1396 | Q7Z4N2 | |
| QSTLTDIQGQIEQQS | 251 | Q8N3L3 | |
| EVTQQQATQAEGQLL | 146 | Q6PJ69 | |
| QQQTTLQVTVNVIKE | 716 | O75962 | |
| TENEEQTQLTQNAVS | 571 | P22459 | |
| SQTQATLQQASQQVL | 1431 | Q9Y6N6 | |
| SNIQENTQTPTVQEE | 151 | Q13765 | |
| QDSTQVTAQVQLVVA | 41 | Q9BZK3 |